Bronstein, Gewirtz & Grossman, LLC Notifies Spero Therapeutics, Inc. (SPRO)Â Shareholders of Class Action and Encourages Investors to Contact the Firm
businesswire.com
news
2022-06-03 00:00:00

June 03, 2022 11:00 AM Eastern Daylight Time NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Spero Therapeutics, Inc. ('Spero' or the 'Company') (NASDAQ: SPRO) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired Spero securities between October 28, 2021 and May 2, 2022, (the 'Class Period'). Such investors are encouraged to join this case by visiting the firm's site: www.
